Guidance on shared care agreements with unregulated providers for children and young people with gender incongruence
NHS England has cascaded
new guidance that advises general practitioners against shared care agreements with unregulated providers in relation to hormone medication to children and young people under 18 as a response to gender incongruence / gender dysphoria.
The guidance outlines that:
- a GP must refuse to support the private prescribing or supply of GnRH analogues
- a GP should refuse to support an unregulated provider in the prescribing or supply of alternative medications that may be used to suppress pubertal development
- a GP should refuse to support an unregulated provider in the prescribing of exogenous hormones.
The cascaded letter states an unregulated provider is one that is not registered with, or regulated by, a UK health regulator such as the Care Quality Commission or Health Inspectorate Wales. More information is available in the letter.
In all cases, safeguarding measures should be considered where the administration of a medicine from an unregulated source presents an immediate safety risk.